Possible role of Stat5a in rat mammary gland carcinogenesis

Breast Cancer Research and Treatment

Volumn 88, Issue 3, 2004, Pages 263-272

  Shan, Liang ^a   Yu, Minshu ^a   Clark, Bradly D ^a   Snyderwine, Elizabeth G ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CCR   (United States)

Author keywords

Breast; Carcinoma; Heterocyclic amine; Human; Mammary gland; Rat; Stat5a

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLINE; STAT5A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CARCINOMA IN SITU; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STATISTICAL ANALYSIS; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MILK PROTEINS; MODELS, ANIMAL; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 12344305209     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-0805-2     Document Type: Article

References (27)

1. Buettner R, Mora LB, Jove R: Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954, 2002
2. Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A: STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197: 157-168, 2003
3. Bromberg J: Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142, 2002
4. Yu H, Jove R: The stats of cancer- new molecular targets come of age. Nature Rev 4: 97-105, 2004
5. Levy DE, Darnell JE: Stats: transcriptional control and biological impact. Nature Rev Mol Cell Biol 3: 651-662, 2002
6. Kazansky AV, Raught B, Lindsey SM, Wang Y, Rosen JM: Regulation of mammary gland factor/Stat5a during mammary gland development. Mol Endocrinol 9: 1598-1609, 1995
7. Liu Z, Robinson GW, Henninghausen L: Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol 10: 1496-1506, 1996
8. Liu X, Robinson GW, Wagner K-U, Garrett L, Wynshaw-Boris A, Henninghausen L: Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Develop 11: 179-186, 1997
9. Humphreys RC, Henninghausen L: Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Diff 10: 685-694, 1999
10. Miyoshi K, Shillingford JM, Smith GH, Grimm SI, Wagner K-U, Oka T, Rosen JM, Robinson GW, Henninghausen L: Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 155: 531-542, 2001
11. Brockman JL, Schroeder MD, Schuler LA: PRL activates the cyclic D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 16: 774-784, 2002
12. Friedrichsen BN, Richter HE, Hansen JA, Rhodes CJ, Nielsen JH, Billestrup N, Møldrup A: Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclic D2 gene and proliferation of rat pancreatic β-cells. Mol Endocrinol 17: 945-968, 2003
13. de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L: STAT5 activation by BCR-Ab1 contributes to transformation of K562 leukemia cells. Blood 94: 1108-1112, 1999
14. Ren S, Cai HR, Li M, Furth PA: Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 21: 4335-4339, 2002
15. Hsiao J-R, Jin Y-T, Tsai S-T, Shiau A-L, Wu C-L, Su W-C: Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Brit J Cancer 89: 344-349, 2003
16. Watson CJ, Miller WR: Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Brit J Cancer 71: 840-844, 1995
17. Cotarla I, Ren S, Zhang Y, Gehan E, Singh B, Furth PA: Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 108: 665-671, 2004
18. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ: Biology of disease. Comparative study of human and rat mammary tumorigenesis. Lab Invest 62: 244-278, 1990
19. Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET, Snyderwine EG: cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 23: 1561-1568, 2002
20. Ghoshal A, Preisegger KH, Takayama S, Thorgeirsson SS, Snyderwine EG: Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat. Carcinogenesis 15: 2429-2433, 1994
21. Snyderwine EG, Thorgeirsson UP, Venugopal M, Robert-Thomson SJ: Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets. Nutr Cancer 31: 160-167, 1998
22. Yu M, Snyderwine EG: H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer. Carcinogenesis 23: 2123-2128, 2002
23. Costa I, Solanas M, Escrich E: Histopathologic characterization of mammary neoplastic lesions induced with 7,12-dimethylbenz(α)anthracene in the rat. Arch Pathol Lab Med 126: 915-927, 2002
24. Roberts-Thomson SJ, Snyderwine EG: mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors. Breast Cancer Res Treat 51: 99-107, 1998
25. Qiu C, Shan L, Yu M, Snyderwine EG: Deregulation of the cyclic D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 63: 5674-5678, 2003
26. Jang TJ, Kang MS, Kim H, Kim DH, Lee JI, Kim JR: Increased expression of cyclic Dl, cyclic E and p21(Cipq) associated with decreased expression of p27(Kip1) in chemically induced rat mammary carcinogenesis. Japan J Cancer Res 91: 1222-1232, 2000
27. Alkarain A, Slingerland J: Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 6: 13-21, 2004